Digestive Diseases and Sciences

, Volume 56, Issue 12, pp 3551–3558 | Cite as

Montelukast Was Inefficient in Maintaining Steroid-Induced Remission in Adult Eosinophilic Esophagitis

  • Alfredo J. Lucendo
  • Livia C. De Rezende
  • Susana Jiménez-Contreras
  • Jose Luis Yagüe-Compadre
  • Jesús González-Cervera
  • Teresa Mota-Huertas
  • Danila Guagnozzi
  • Teresa Angueira
  • Sonia González-Castillo
  • Ángel Arias
Original Article


Background and Aims

Leukotriene D4 is produced by and functions as a chemotactic factor for eosinophils. Eosinophilic esophagitis (EoE) is characterized by esophageal eosinophilic infiltration, determining structural changes and dismotility symptoms. Montelukast, a selective leukotriene D4 receptor antagonist, has gained increasing consideration as a therapeutic agent for EoE. However, limited available information has shown that montelukast is not effective in reducing eosinophilic infiltration. Our paper aims at evaluating whether montelukast could be consider as a steroid-sparing therapy by assessing its efficacy in maintaining both clinical and histopathological remission achieved after topical corticosteroids in adult EoE patients.


Eleven consecutively diagnosed adult EoE patients were prospectively studied. Esophageal biopsies were obtained before and after a 6-month treatment with fluticasone propionate 400 μg/twice a day. Immediately after that, montelukast 10 mg/day was instituted. A new endoscopy was foreseen after a new 3-month period, or as soon as the patients presented esophageal symptoms. Symptoms were assessed by using a questionnaire before and after fluticasone propionate treatment and after montelukast therapy.


Eosinophils density into the esophageal epithelium and lamina propria was significantly reduced after a 6-month treatment with topical steroids (P = 0.003) and increased to levels similar to baseline level into the first 3 months after treatment with montelukast. Baseline symptom scores significantly decreased after treatment with topical steroids (P = 0.003) and increased again after montelukast therapy, but baseline levels improved.


Montelukast was not efficient in maintaining the histopathological or clinical response achieved by topical steroids in adult EoE patients.


Eosinophilic esophagitis Allergic esophagitis Montelukast Anti-leukotriene Leukotriene D4 Dysphagia 



We would like to thank Dr Jose María Tenias Burillo for providing us with his methodological support. This study was funded in part by the Castilla-La Mancha Health Research Foundation (Fundación para la Investigación Sanitaria de Castilla-La Mancha or FISCAM), grant number AN-2008/21.

Conflict of interest

None of the authors have any conflict of interest or affiliation with any of the institutions, organizations or companies mentioned in this manuscript.


  1. 1.
    Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. J Allergy Clin Immunol. 2011. (Epub ahead of print). doi: 10.1016/j.jaci.2011.02.040
  2. 2.
    Lucendo AJ, Lucendo B. An update on the immunopathogenesis of eosiniophilic esophagitis. Expert Rev Gastroenterol Hepatol. 2010;4:141–148.PubMedCrossRefGoogle Scholar
  3. 3.
    Simon D, Marti H, Heer P, et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Inmunol. 2005;115:1090–1092.CrossRefGoogle Scholar
  4. 4.
    Martín-Muñoz MF, Lucendo AJ, Navarro M, et al. Food allergy and eosinophilic esophagitis: two cases studies. Digestion. 2006;74:49–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Moawad FJ, Veerappan G, Lake JM, et al. The correlation between eosinophilic esophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31:509–515.PubMedCrossRefGoogle Scholar
  6. 6.
    González-Castillo S, Árias A, Lucendo AJ. Treatment of eosinophilic esophagitis: how should we manage the disease? J Clin Gastroenterol. 2010;44:663–671.PubMedCrossRefGoogle Scholar
  7. 7.
    Liacouras CA, Wenner WJ, Brown K, et al. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26:380–385.PubMedCrossRefGoogle Scholar
  8. 8.
    Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Ciln Gastroenterol Hepatol. 2008;6:165–173.CrossRefGoogle Scholar
  9. 9.
    Borda F, Jiménez FJ, Martínez Peñuela JM, et al. Eosinophilic esophagitis: an underdiagnosed entity? Rev Esp Enf Dig. 1996;88:701–704.Google Scholar
  10. 10.
    Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526–1537.PubMedCrossRefGoogle Scholar
  11. 11.
    Teitelbaum J, Fox V, Twarog F, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;122:1216–1225.PubMedCrossRefGoogle Scholar
  12. 12.
    Aceves SS, Dohil R, Newbury RO, et al. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2005;116:705–706.PubMedCrossRefGoogle Scholar
  13. 13.
    Lucendo AJ, Pascual-Turrión JM, Navarro M, et al. Endoscopic, bioptic and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy. 2007;39:765–771.PubMedCrossRefGoogle Scholar
  14. 14.
    Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206.PubMedCrossRefGoogle Scholar
  15. 15.
    Markham A, Faulds D. Montelukast. Drugs. 1998;55:251–256.CrossRefGoogle Scholar
  16. 16.
    Sampson A, Holgate S. Leukotriene modifiers in the treatment of Asthma. Look promising across the board of asthma severity. BMJ. 1998;316:1257–1258.PubMedCrossRefGoogle Scholar
  17. 17.
    Ramsay CF, Pearson D, Mildenhall S, et al. Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial. Thorax. 2010;66:7–11.PubMedCrossRefGoogle Scholar
  18. 18.
    Jarvis B, Markham A. Montelukast: a review of its therapeutic potential in persistent asthma. Drugs. 2000;59:891–928.PubMedCrossRefGoogle Scholar
  19. 19.
    Attwood SE, Lewis CJ, Bronder CS, et al. Eosinophilic esophagitis: a novel treatment using Montelukast. Gut. 2003;52:181–185.PubMedCrossRefGoogle Scholar
  20. 20.
    Stumphy J, Al-Zubeidi D, Guerin L, et al. Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future. Dis Esophagus 2011;24:229–341.Google Scholar
  21. 21.
    Zaninotto G, Costantini M, Molena D, et al. Treatment of esophageal achalasia with laparoscopic Heller myotomy and Dor partial anterior fundoplication: prospective evaluation of 100 consecutive patients. J Gastrointest Surg. 2000;4:282–289.PubMedCrossRefGoogle Scholar
  22. 22.
    Bisgaard H. Leukotriene modifiers in pediatric asthma management. Pediatrics. 2001;107:381–390.PubMedCrossRefGoogle Scholar
  23. 23.
    Arora AS, Yamazaki K. Eosinophilic esophagitis: asthma of the esophagus? Clin Gastroenterol Hepatol. 2004;2:523–530.Google Scholar
  24. 24.
    Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol. 2001;108:954–961.PubMedCrossRefGoogle Scholar
  25. 25.
    Spergel J, Rothenberg ME, Fogg M. Eliminating eosinophilic esophagitis. Clin Inmunol. 2005;115:131–132.CrossRefGoogle Scholar
  26. 26.
    Nurko S, Rosen R, Furuta GT. Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol. 2009;104:3050–3057.PubMedCrossRefGoogle Scholar
  27. 27.
    Lucendo AJ, Castillo P, Martín-Chávarri S, et al. Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases. Eur J Gastroenterol Hepatol. 2007;19:417–424.PubMedCrossRefGoogle Scholar
  28. 28.
    Lucendo AJ, Bellón T, Lucendo B. The role of mast cell in eosinophilic esophagitis. Pediatr Allergy Immunol. 2009;20:512–518.PubMedCrossRefGoogle Scholar
  29. 29.
    Metcalfe DD, Baram D, Mekory YA. Mast cells. Physiol Rev. 1997;77:1033–1079.PubMedGoogle Scholar
  30. 30.
    Rothenberg ME, Mishra A, Collins MH, et al. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Inmunol. 2001;108:891–894.CrossRefGoogle Scholar
  31. 31.
    Daikh BE, Ryan CK, Schwartz RH. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. Ann Allergy Asthma Immunol. 2003;90:23–27.PubMedCrossRefGoogle Scholar
  32. 32.
    Sinharay R. Eosinophilic esophagitis: treatment using montelukast. Gut. 2003;52:1228–1229.PubMedCrossRefGoogle Scholar
  33. 33.
    Gupta SK, Peters-Golden M, Fitzgerald JF, et al. Cysteinil leukotriene levels in esophageal mucosal biopsies of children with eosinophilic inflamation: are they all the same? Am J Gastroenterol. 2006;101:1125–1128.PubMedCrossRefGoogle Scholar
  34. 34.
    Straumann AT. The natural history and complications of eosinophilic esophagitis. Gastrointestinal Endosc Clin North Am. 2008;18:99–118.CrossRefGoogle Scholar
  35. 35.
    Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104:828–833.PubMedCrossRefGoogle Scholar
  36. 36.
    Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Inmunol. 2003;112:796–797.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Alfredo J. Lucendo
    • 1
  • Livia C. De Rezende
    • 1
  • Susana Jiménez-Contreras
    • 1
  • Jose Luis Yagüe-Compadre
    • 3
  • Jesús González-Cervera
    • 4
  • Teresa Mota-Huertas
    • 3
  • Danila Guagnozzi
    • 1
  • Teresa Angueira
    • 1
  • Sonia González-Castillo
    • 1
  • Ángel Arias
    • 2
  1. 1.Department of GastroenterologyHospital General de TomellosoTomelloso, Ciudad RealSpain
  2. 2.Research UnitComplejo Hospitalario La Mancha CentroAlcázar de San Juan, Ciudad RealSpain
  3. 3.Department of PathologyComplejo Hospitalario La Mancha CentroAlcázar de San Juan, Ciudad RealSpain
  4. 4.Department of AllergyHospital General de TomellosoTomelloso, Ciudad RealSpain

Personalised recommendations